• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Sar Televenture Ltd
Industry :  Transmisson Line Towers / Equipment
BSE Code
ISIN Demat
Book Value()
91900
INE0PUC01020
159.9453213
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SARTELE
38.18
448.07
EPS(TTM)
Face Value()
Div & Yield %
2.34
2
0
 

Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter
Jun 01,2026
Net profit of Gufic BioSciences rose 183.68% to Rs 21.90 crore in the quarter ended March 2026 as against Rs 7.72 crore during the previous quarter ended March 2025. Sales rose 22.83% to Rs 251.82 crore in the quarter ended March 2026 as against Rs 205.02 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.81% to Rs 64.21 crore in the year ended March 2026 as against Rs 69.65 crore during the previous year ended March 2025. Sales rose 15.15% to Rs 944.01 crore in the year ended March 2026 as against Rs 819.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales251.82205.02 23 944.01819.81 15
OPM %18.7512.87 -16.0316.60 -
PBDT36.6018.37 99 117.38115.21 2
PBT28.9510.52 175 86.5594.14 -8
NP21.907.72 184 64.2169.65 -8